Watson recalls batch oversized arrhythmia drug
Watson Pharmaceuticals has voluntarily withdrawn one lot of its arrhythmia drug propafenone HCl in the US after the tablets were found to contain slightly higher levels of the drug’s API.
Archives for March 24, 2009
UK and Australia clear Ranbaxy’s Paonta Sahib plant
Regulators in the UK and Australia have issued GMP certificates for Ranbaxy Laboratories' Paonta Sahib plant after a joint inspection deemed manufacturing practices were up to code.
Snapshot of technologies at Interphex 2009
St Patrick’s Day celebrations weren’t the only thing bringing people together in New York last week as the pharmaceutical manufacturing and outsourcing industries gathered at the Jacob K Javits convention centre for Interphex 2009.
HP claims it can cut costs for 80% flexo printing
Hewlett-Packard has made its high-volume digital press commercially available, which it claims can cut waste, warehousing and environmental impact compared to analogue printing.
Vetter launches VPI subsidiary
Vetter Pharma-Fertigung (VPF), a specialist provider of pre-filled injection systems, has formed a new subsidiary, Vetter Pharma International (VPI) to take charge of sales, marketing and customer services.
MDRNA signs deal with second Swiss major
US RNA interference (RNAi) specialist MDRNA has signed a non-exclusive licensing deal granting Swiss drug giant Novartis access to its liposomal siRNA delivery technology platform.